AXDX
Accelerate Diagnostics Inc
Price:  
1.18 
USD
Volume:  
26,100.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AXDX EV/EBITDA

-2658.3%
Upside

As of 2025-02-16, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 68.02 mil USD. AXDX's TTM EBITDA according to its financial statements is -35.25 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 18.2x - 20.2x 18.8x
Forward P/E multiples 21.1x - 22.7x 21.9x
Fair Price (31.19) - (30.03) (30.19)
Upside -2743.0% - -2645.1% -2658.3%
1.18 USD
Stock Price
(30.19) USD
Fair Price

AXDX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-10 -1.97
2025-02-07 -1.99
2025-02-06 -1.99
2025-02-05 -1.99
2025-02-04 -2.02
2025-02-03 -2.03
2025-01-31 -2.05
2025-01-30 -2.03
2025-01-29 -2.02
2025-01-28 -1.97
2025-01-27 -2.08
2025-01-24 -1.92
2025-01-23 -1.91
2025-01-22 -1.89
2025-01-21 -1.89
2025-01-17 -1.85
2025-01-16 -1.89
2025-01-15 -1.89
2025-01-14 -1.86
2025-01-13 -1.89
2025-01-10 -1.94
2025-01-08 -1.88
2025-01-07 -1.92
2025-01-06 -1.96
2025-01-03 -2.05
2025-01-02 -1.99
2024-12-31 -1.94
2024-12-30 -1.91
2024-12-27 -1.87
2024-12-26 -1.88
2024-12-24 -1.85
2024-12-23 -1.87
2024-12-20 -1.92
2024-12-19 -1.94
2024-12-18 -1.94
2024-12-17 -1.91
2024-12-16 -1.94
2024-12-13 -2.02
2024-12-12 -2.05
2024-12-11 -2.03
2024-12-10 -2.10
2024-12-09 -2.16
2024-12-06 -2.21
2024-12-05 -2.21
2024-12-04 -2.30
2024-12-03 -2.21
2024-12-02 -2.26
2024-11-29 -2.27
2024-11-27 -2.23
2024-11-26 -2.26